Authors

• Denis Poddubnyy (ORCID: https://orcid.org/0000-0002-4537-6015)
• Lianne S. Gensler (ORCID: https://orcid.org/0000-0001-6314-5336)
• Thibaud Coroller (ORCID: https://orcid.org/0000-0001-7662-8724)
• Rhydian Windsor
• Amir Jamaludin (ORCID: https://orcid.org/0000-0002-0096-5625)
• Gregory Ligozio
• Aimee Readie
• Andrew Zisserman (ORCID: https://orcid.org/0000-0002-8945-8573)
• Timor Kadir (ORCID: https://orcid.org/0000-0002-4414-2401)
• Jürgen Braun (ORCID: https://orcid.org/0000-0002-9156-5095)
• Mikkel Østergaard (ORCID: https://orcid.org/0000-0003-3690-467X)
• Pedro Machado (ORCID: https://orcid.org/0000-0002-8411-7972)
• Sarim Ather (ORCID: https://orcid.org/0000-0001-9614-5033)
• Brian Porter

Institutions

• University of Copenhagen (DK)
• Department of Health and Social Care (GB)
• University Health Network (CA)
• Queen Mary University of London (GB)
• University of California, San Francisco (US)
• University of Toronto (CA)
• London North West Healthcare NHS Trust (GB)
• Northwick Park Hospital (GB)
• Glostrup Hospital (DK)
• Rigshospitalet (DK)
• National Institute for Health and Care Research (GB)
• Humboldt-Universität zu Berlin (DE)
• University of Oxford (GB)
• German Rheumatism Research Centre (DE)
• Praxis (United States) (US)
• The Garden Church (US)
• Novartis (United States) (US)
• Science Oxford (GB)
• Oxford University Hospitals NHS Trust (GB)
• National Hospital for Neurology and Neurosurgery (GB)
• Tris Pharma (United States) (US)
• University College London (GB)
• Freie Universität Berlin (DE)
• University of San Francisco (US)
• Charité - Universitätsmedizin Berlin (DE)
• Ruhr University Bochum (DE)

Publication Details

Journal

Lara D. Veeken

Published

2025-06-09

DOI

https://doi.org/10.1093/rheumatology/keaf323

Citations

2

Primary Topic

Spondyloarthritis Studies and Treatments

Type

article

Field-Weighted Citation Impact

3.34

Funders

• Amgen
• Eli Lilly and Company
• Pfizer
• Novartis
• Sanofi
• Gilead Sciences
• Celgene
• Regeneron Pharmaceuticals
• Medac